TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹3,026 Cr | ₹3,937 Cr | ₹5,297 Cr | ₹4,018 Cr | ₹4,825 Cr |
What is the latest Total Debt ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹3,026 Cr |
| Mar2024 | ₹3,937 Cr |
| Mar2023 | ₹5,297 Cr |
| Mar2022 | ₹4,018 Cr |
| Mar2021 | ₹4,825 Cr |
How is Total Debt of TORRENT PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,026 Cr | -23.15 | |
| Mar2024 | ₹3,937 Cr | -25.67 | |
| Mar2023 | ₹5,297 Cr | 31.84 | |
| Mar2022 | ₹4,018 Cr | -16.73 | |
| Mar2021 | ₹4,825 Cr | - | |
Compare Total Debt of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹128,343.3 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹90,069.9 Cr | -0.3% | -3% | -24.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.3% |
1.6% |
12.1% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses